Wolfgang Michael Korn

22PUBLICATIONS
123CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer.

Jingyuan Wang, Joanne Xiu, Francesca Battaglin

|Jul 03, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system.

Kai Zimmer, Florian Kocher, Gerold Untergasser

|Jun 02, 2023
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.

Vaia Florou, Andrew Elliott, Matthew H Bailey

|May 01, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Justin Hwang, Xiaolei Shi, Andrew Elliott

|Sep 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets.

Florian Kocher, Alberto Puccini, Gerold Untergasser

|Jun 02, 2022
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.

Jennifer L Leddon, Shuchi Gulati, Sulsal Haque

Pageof 4